5.8
[]. D. Jayaraju and Anand K. Kondapi. Anti-cancer copper salicylaldoxime complex inhibits topoisomerase II catalytic activity. Current Science. Vol. 8, No. 7 (0 October 00), pp. 787-79
[]. W Ligett and L Biefeld. Separation and Determination of Lead with Salicylaldoxime. Ind. Eng. Chem. Anal. Ed. 94, , , 8-85.
[]. Ann H Cory, et al. Phenolic compounds, sodium salicylate and related compounds, as inhibitors of tumor cell growth and inducers of apoptosis in mouse leukemia L0 cells. In Vivo. 005 Jan-Feb;9():-5.
[4]. Chandrika Ravindran Preetha, et al. Removal of toxic uranium from synthetic nuclear power reactor effluents using uranyl ion imprinted polymer particles. Environ Sci Technol. 006 May ;40(9):070-4.
[5]. Filippo Minutolo, et al. Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor beta. J Med Chem. 009 Feb ;5():858-67.
H0-H5-H9-H5
P6-P64-P70-P7-P80-P0+P5-P04+P40-P0-P6+P64-P405-P50